The largest database of trusted experimental protocols

11 protocols using ab25117

1

Cochlea Protein Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
After decapitation of the animals, the bulla was quickly removed and placed in ice-cold 10 mM PBS. The bony capsule and the lateral wall of the cochlea were removed. Cochlea sample included the organ of corti, and the modiolus was dissected. Specimen was homogenized in a RIPA lysis buffer (sc-24948, Santa Cruz Biotechnology). Homogenate was centrifuged, and supernatant solution was collected. Total protein amount was determined according to the Bradford method (Bradford, 1976) using bovine serum albumin as a protein concentration standard. Protein was separated using SDS gel and transferred into a nitrocellulose membrane. After blocking, the membrane was incubated with primary antibodies for rabbit polyclonal to SDF-1 (AB 25117, 1:1,000; Abcam, Cambridge, UK) and β-actin (AB, ab8227, 1:2,000; Abcam) (as an internal control) at 4°C overnight. After rinsing to eliminate unbound primary antibody, the membrane was incubated with horseradish peroxidase-conjugated anti-rabbit IgG secondary antibody (AB, 6721, 1:2,000; Abcam) for 2 hours at room temperature. The protein bands were visualized using an enhanced chemiluminescence kit (Amersham Pharmacia Biotech Inc., Piscataway, NJ, USA) and quantified by TotalLab software (Wales, UK) (Niknazar et al., 2016, 2017).
+ Open protocol
+ Expand
2

Evaluating Wound Vascularization and Healing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Upon wound closure, mice were euthanized and wounds were harvested with an 8 mm biopsy punch (Integra Miltex, Plainsboro, New Jersey). Skin tissues were fixed in 4% paraformaldehyde overnight followed by serial dehydration in ethanol and embedding in paraffin. In order to assess dermal thickness, 5-μm sections were then stained for H&E and photographed at 10X magnification.
Immunofluorescence staining for CD31 and SDF-1 was then performed to assess wound vascularization. Frozen tissue samples were prepared by OCT Compound (Sakura Finetek US, Torrance, California) and cryosectioned for immunohistochemistry.27 Slides underwent antigen retrieval using 0.01M sodium citrate buffer in PBS solution, followed by blocking for 1 hour with 5% goat serum in PBS. Sections were then incubated in CD31 antibody (ab28364; Abcam, Cambridge, Massachusetts) or SDF-1 antibody (ab25117; Abcam, Cambridge, Massachusetts) overnight, followed by a secondary antibody. Lastly, slides were DAPI-stained for cell nuclei and mounted. ImageJ was used to binarize immunofluorescent images taken with the same excitation, gain, and exposure settings.28 (link) Intensity threshold values were set automatically and quantification of staining was determined by pixel-positive area normalized to dermal area. All histology was conducted in quadruplicate.
+ Open protocol
+ Expand
3

Recombinant CXCL12 Peptide and Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rat recombinant CXCL12 peptide (Z02860) was purchased from Genscript (Piscataway, NJ, USA). CXCR4 antagonists AMD3100 (A5602) and Astrocyte metabolic inhibitor fluorocitrate (F9634) were purchased from Sigma (St. Louis, MO, USA). Anti‐CXCL12 neutralizing antibody (ab25117) and control IgG (ab133470) antibody were purchased from Abcam (Cambridge, MA, USA). AMD3100, Anti‐CXCL12 neutralizing antibody and control IgG were dissolved in sterilized saline. CXCL12 peptide and fluorocitrate were prepared in 1% dimethyl sulfoxide (DMSO).
Antibodies against GFAP (ab10062), CXCL12 (ab25117),14 CXCR4 (ab197203),15 NeuN (ab104224), and OX42 (ab1211) were purchased from Abcam. Antibodies against CXCR4 (11073‐2‐AP)16 were purchased from Proteintech (San Ying biotechnology, Wuhan, China). Antibody against Actin (sc‐8432) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti‐mouse IgG (H + L) (#4408) and anti‐Rabbit IgG (H + L) (#4413) were purchased from Cell Signaling Technology (CST) (Danvers, MA, USA).
+ Open protocol
+ Expand
4

Protein Extraction and Western Blotting

Check if the same lab product or an alternative is used in the 5 most similar protocols
A protein extraction kit (Beyotime, P0013J) was used to extract the total protein from rat skin ulcer tissues according to the manufacturer’s protocol. Prior to centrifugation at 12,000g for 15 min at 4 °C, TissueLyser beads were added to the centrifugation tubes to assist with protein cleavage. The upper layer of lipid was removed, and a BCA Protein Assay Kit (Beyotime, China) was using to determine the protein concentration in each extract. Western blotting was performed according to a standard WB protocol (Yukhananov, Chimento & Marlow, 2022 (link)). ImageJ software (v 1.8.0) was used to quantify protein levels, and GAPDH expression served as an internal standard. The primary antibodies used for WB were as follows: anti-CXCR4 (ab124824, 1:100; Abcam), anti-SDF1 (ab25117, 1:1,000; Abcam), and anti-GAPDH (ab9485, 1:2500; Abcam). The secondary antibody was goat anti-rabbit IgG H&L (HRP) (ab6721, 1:2000; Abcam).
+ Open protocol
+ Expand
5

Osteoarthritis Treatment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
AMD3100 (ab120718, Purity: > 99%), LY303511 (ab145193) and primary antibodies for CXCL12 (ab25117), CXCR4 (ab124824), aggrecan (ab36861) ADAMTS-5 (ab41037), Smad3(ab52903), TIMP-3 (ab39184) and TGF-β1 (ab92486) were purchased from Abcam (Cambridge, UK), p-Akt (ab38449), p-Smad3 (ab122028) were purchased from Optomics (Hermiston, OR, USA).CXCL12a and CXCL12b ELISA kits were purchased from Tsz Biosciences (Boston, MA, USA). Alzet osmotic mini-pumps (2006) were purchased from DURECT Corporation (Cupertino, CA, USA). Recombinant rat CXCL12a, IL-1 and other reagents were purchased from Beyotime (Shanghai, China).
+ Open protocol
+ Expand
6

Fixation and Cryosectioning of Posterior Eyecup

Check if the same lab product or an alternative is used in the 5 most similar protocols
After the anterior segments were removed, the posterior eyecup was fixed in 4% PFA overnight and treated in 10% sucrose for two hours before being incubated in 30% sucrose overnight. Eyecups were imbedded in optimal cutting temperature compound (OCT, Tissue Tek, USA) and cryosections were cut at 10 μm intervals. Cells grown on glass coverslips or tissue slices were fixed for 10 minutes at room temperature in 4% paraformaldehyde. PBS containing 1% bovine serum albumin and 0.2% Triton X-100 were added for 30 minutes. The following primary antibodies were used: Pecam1 (Santa Cruz, sc-46694), Iba1 (Abcam, ab178847), Sdf1 (Abcam, ab25117), Cxcr4 (Abcam, ab181020), Ki67 (CST, 9129). Then, the samples were stained with secondary antibodies for 1 hours at 37 °C).
+ Open protocol
+ Expand
7

Osteoarthritis Molecular Mechanism Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
AMD3100 (ab120718) and primary antibodies for CXCL12 (ab25117), CXCR4 (ab124824), ACAN (ab36861), SOX-9 (ab3697), RUNX-2 (ab76957), ADAMTS-4/5 (ab185722, ab41037), the aggrecan neo-epitope 374ARGSV (ab3773), PNCA (ab29), SB202190 (ab120638), U-0126 (ab120241), and C59 (ab142216) were purchased from Abcam (Cambridge, UK). Antibodies for ERK (#9102), phospho-ERK (#4377), JNK (#9258), phospho-JNK (#4668), p38 (#8690), phospho-p38 (#4511), p65 (#8242), phospho-p65 (#3033), IκBα (#4812), phospho-IκBα (#2859), β-catenin (#9582), GSK-3β (#12456), SURVIVIN (#2808), Cyclin D1 (#2978), and MMP-7 (#3301) were purchased from Cell Signaling Technology (Beverly, MA, USA). CXCL12a and CXCL12b ELISA kits were purchased from Tsz Biosciences (Boston, MA, USA). Alzet osmotic mini-pumps (2004) were purchased from DURECT Corporation (Cupertino, CA, USA). Recombinant rat CXCL12a and other reagents were purchased from Beyotime (Shanghai, China).
+ Open protocol
+ Expand
8

Western Blot Analysis of SDF-1 and CXCR4

Check if the same lab product or an alternative is used in the 5 most similar protocols
The proteins were extracted from heart samples using RIPA Lysis Buffer [Sangon Biotech (Shanghai), Co., Ltd.]. Western blotting was performed with anti-SDF-1 (ab25117, abcam), anti-CXCR4 (ab124827, abcam), and anti-GAPDH (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, United States) primary antibodies and with relevant secondary anti-bodies (Santa Cruz Biotechnology, Inc.) as described previously (Chen et al., 2015 (link)).
+ Open protocol
+ Expand
9

Western Blot Analysis of Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein expression levels were analysed by Western blot analysis as described previously.15, 18 The primary antibodies used were as follows: anti‐SDF‐1α (ab25117; Abcam), anti‐fibronectin (F3648; Sigma‐Aldrich), anti‐α‐SMA (ab5694; Abcam), anti‐collagen I (ab34710; Abcam), anti‐vimentin (SAB1305447, Sigma‐Aldrich), anti‐CXCR4 (BA0747‐2; Boster), anti‐p‐GSK3β (ser 9) (5558; Cell Signaling Technology), anti‐β‐catenin (610 154; BD Transduction Laboratories), anti‐PAI‐1 (AF3828; R&D Systems), anti‐snail1 (ab180714; Abcam), anti‐MMP‐7 (104 658; GTX), anti‐E‐cadherin (3195; Cell Signaling Technology), anti‐active β‐catenin (19807s; Cell Signaling Technology), anti‐Kim1 (BA3537; Boster, Wuhan, China), anti‐α‐tubulin (RM2007, Ray Antibody Biotech, Beijing, China) and p‐STAT antibody sampler kit (9914; Cell Signaling Technology), p‐JAK family antibody sampler kit (97 999; Cell Signaling Technology), STAT antibody sampler kit (9939; Cell Signaling Technology) and anti‐GAPDH (RM2000, Ray Antibody Biotech, Beijing, China).
+ Open protocol
+ Expand
10

Intrathecal Drug Delivery in Rat Pain Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Drugs were delivered intrathecally. The intrathecal catheterization was performed according to our previous method.22 (link) In brief, a polyethylene-10 (OD, 0.61 mm; ID, 0.28 mm) catheter was inserted into the rat’s subarachnoid space through L5–L6 intervertebral space, and the tip of the catheter was located at the L5 spinal segmental level. The CXCR4-specific antagonist AMD3100 and the NF-κB activation inhibitor PDTC were purchased from Sigma (St. Louis, USA) and freshly dissolved daily in normal sterile saline prior to use. Anti-CXCL12 neutralizing antibody (Abcam, ab25117) and anti-IgG antibody (for control) were purchased from Abcam (Massachusetts, USA) and diluted with sterile artificial cerebrospinal fluid containing 126.6 mM NaCl, 2.5 mM KCl, 2.0 mM MgCl2, and 1.3 mM CaCl2. The specific MEK (extracellular signal-regulated kinase (ERK)) inhibitor PD98059 was purchased from Sigma and was dissolved in sterile saline containing 10% DMSO. The intrathecal injection of drug was performed on 8:00 a.m. daily, the time which was 30 min before behavioral test. The doses of AMD3100 (5, 10, 20 µg/10 μl),9 (link),13 (link) anti-CXCL12 neutralizing antibody (4 µg/10 μl),8 (link) PDTC (0.5 µg/10 μl),23 (link),24 (link) and PD98059 (10 µg/10 μl)25 (link) used in this experiment were based on those used in previous studies.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!